First Databank (FDB), a leading provider of integrated drug knowledge, today announced the company’s medication reconciliation solution, FDB MedsTracker, has achieved 2014 Edition Ambulatory and Inpatient Modular EHR ONC Health IT Certification. The solution was certified on by ICSA Labs, an Office of the National Coordinator-Authorized Certification Body (ONC-ACB) and is compliant in accordance with the criteria adopted by the Secretary of Health and Human Services (HHS).
This certification designates that FDB MedsTracker is capable of supporting healthcare providers with Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA). FDB MedsTracker meets multiple criteria for Ambulatoryand Inpatient Modular EHR ONC Health IT Certification, including medication reconciliation, clinical quality measures and e-prescribing. For a complete list of the criteria certified, please visit the FDB website.
“As Meaningful Use criteria evolve, so do the requirements for effective electronic clinical and medication reconciliation,” said Dewey Howell, MD, PhD, vice president of clinical applications, First Databank. “With this certification, our goal is to enable our customers to meet the requirements for some of the most challenging areas such as those for medication reconciliation, clinical quality measures and e-prescribing. We will now work together to develop an embedded solution so that our health information system partners can more easily integrate this medication reconciliation functionality within their systems.”
ICSA Labs, an independent division of Verizon, offers vendor-neutral testing and certification. 2014 Edition ONC Health IT Certification is awarded to those technologies that are capable of meeting the more rigorous testing criteria developed to support providers and hospitals with Stage 2 meaningful use, which focuses on the capability of health IT to deliver higher quality patient care and exchange clinical information securely.
Electronic medication reconciliation, previously a menu objective for Stage 1 Meaningful Use requirements and deferred by more than 70% of eligible hospitals attesting for Stage 1, is now required for Stage 2. FDB MedsTracker has demonstrated immediate and measurable improvements in the medication reconciliation process. Notable advances reported by customers include increased accuracy of home medication lists; efficiency of discharge medication orders and electronic prescribing; reductions in missed medications, duplicate therapies, and incorrect dosing; and workflow efficiencies with measurable time savings for clinicians.
The additional software relied upon to comply with one or more of the certification criteria include the FDB MedKnowledge™ and FDB OrderKnowledge™ drug databases. Implementation of FDB MedsTracker may require an initial integration set-up fee and a yearly maintenance fee.
FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise medication-related decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver a wide range of valuable, useful, and differentiated solutions. As the company that virtually launched the medication care guidance category, we offer more than three decades of experience in transforming drug knowledge into actionable, targeted, and effective solutions that improve patient safety and healthcare outcomes. For a complete look at our solutions and services please visit www.fdbhealth.com or follow us on Twitter and LinkedIn.
About Hearst Health
FDB is part of the Hearst Health network, which also includes Zynx Health, MCG (formerly Milliman Care Guidelines) and Homecare Homebase. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 76% of discharged patients, 133 million insured individuals, 20 million home health visits, 1.88 billion retail pharmacy prescriptions and 3.26 billion prescription claims. Extensions of the Hearst Health network include Hearst Health Ventures and the Hearst Health Innovation Lab.
About ONC Certification
The ONC Certified HIT Technology program tests and certifies that Health IT technology is capable of meeting the 2014 Edition criteria approved by the Secretary of Health and Human Services (HHS). The certifications include Complete EHRs, which meet all of the 2014 Edition criteria for either eligible provider or hospital technology and EHR Modules, which meet one or more — but not all — of the criteria.
About ICSA Labs
ICSA Labs, an independent division of Verizon, offers third-party testing and certification of security and health IT products, as well as network-connected devices, to measure product compliance, reliability and performance for many of the world’s top security vendors. ICSA Labs is an ISO/IEC 17025:2005 accredited and 9001:2008 registered organization. ICSA Labs is NVLAP accredited as a Health IT Test Lab and is also an ONC-Authorized Certification Body (ONC-ACB) accredited by ANSI to ISO/IEC Guide 65. Visit http://www.icsalabs.com and http://www.icsalabs.com/blogs for more information.
* This Complete EHR/EHR Module is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services. FDB MedsTracker v6 was certified on February 26, 2014.CHPL Product Number: 140032R00.